This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
As the pharmaceutical industry targets $130 billion by 2030 (7) and the medical devices market is eyeing $ 50 billion by 2030 (8), incubators and innovation hubs will be instrumental in harnessing this potential, empowering entrepreneurs to lead the nation’s growth in these sectors. India, with 47 per cent of its 1.4
from 2023 to 2030. Simplified Communication and Coordination : Integrated CDMOs can improve cross-team coordination between research, development, and manufacturing, reducing the need for external hand-offs, technology transfer, and knowledge dissemination. .”
AstraZeneca has announced $50bn investment plans in the US by 2030 for drug manufacturing, and research and development (R&D). It will also support our ambition to reach $80bn in revenue by 2030.” Credit: grandbrothers/Shutterstock.com. Give your business an edge with our leading industry insights.
In the EU, a joint PFAS Restriction Proposal under REACH was submitted, aiming for a full ban by 2028/2030. The PFAS regulatory challenge As a result, in the EU, a joint PFAS Restriction Proposal under REACH was submitted in 2023, aiming for a full ban on all PFAS by 2028/2030. There is worldwide concern around the use of PFAS.
Integrated CDMS solutions also facilitate smoother communication and coordination between stakeholders, enabling faster, data-driven decision-making – all increasingly crucial for maintaining oversight and regulatory compliance. The updated ICH E6 (R3) guidelines introduce a range of critical changes aimed at modernizing clinical trials.
Robert Barrie July 4, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Only 4% of global drugs sales in 2030 will have patent protection. A recent report by GlobalData projects that the share of global drug sales under patent protection will decline by 2030. LanKS via Shutterstock.
Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.
Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.
The goal is to take annual bilateral trade between the two nations to $500 billion by 2030 from the current $190 billion. Leyla Hasanzadeh June 18, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Tech transfer for manufacturing purposes in India will be difficult if Trump imposes import duties on pharmaceuticals.
1 One often overlooked major reason many drug launches underperform comes down to communications. Invest in communications and initiatives that not only maintain that momentum but also reinforce the culture you want to cultivate. Relying solely on the brand team and sales reps often leaves the broader employee base out. References 1.
The new pre-procedure coordination assistant at New York City-based Mount Sinai Hospital’s cardiac catheterization lab may not be human, but she knows how to communicate like one. Projections from various government agencies indicate that by 2030, this shortage will worsen. “She has a soft, calm voice.
The projected growth of the cell and gene therapy market GlobalData estimates that the cell and gene therapy market will achieve global sales of $76.03bn by 2030, up from $5.88bn in 2023, with a compound annual growth rate (CAGR) of 44% over the seven years analysed. of the global market, valued at $39.3bn. of the global sales total.
RPM investments projected to exceed $29 billion by 2030 , healthcare executives are demanding clinically validated solutions that streamline billing and maintain unwavering CMS alignment. Is your Remote Patient Monitoring (RPM) program delivering measurable clinical outcomes, audit-ready compliance, and scalable ROI?
Both companies plan to further innovate partnerships within the medical industry’s digital landscape, aiming to improve patient outcomes and also contribute towards achieving national Healthy China 2030 objectives. Give your business an edge with our leading industry insights.
The World Health Organization (WHO) has set a global goal to have 90% of girls fully vaccinated with the HPV vaccine by 2030. With health education, provision of infrastructure, better communication, and integration into mobile health (mHealth), we can help improve both screening and vaccination in low- and middle-income countries."
Chugai president and CEO Dr Osamu Okuda stated: “We believe that open innovation with external partners, including leading global players, is extremely important for achieving global first-class drug discovery outlined in our growth strategy toward 2030, TOP I 2030. “By Give your business an edge with our leading industry insights.
The global RSV market is set to reach $6.3bn in value by 2030, according to analysis by GlobalData. Around 64 million people of all ages globally every year are impacted by RSV, a common respiratory virus that causes seasonal infections such as the flu. It is also a leading cause of pneumonia and death in infants and older adults.
GlobalData’s Pharma Intelligence Center forecasts global sales for the drug to peak in 2030, generating $7bn in revenue. With entry to the market, Imfinzi stands alone as the only perioperative immunotherapy for muscle-invasive bladder cancer. Give your business an edge with our leading industry insights.
. “The label expansion for Mavyret, coupled with the implementation of ‘test and treat’ models of care, serves as a tool to support the public health community in treating more patients and bringing us closer to achieving the global 2030 elimination goal.”
Care coordination at scale: We assess whether the platform supports care coordination across different settings, featuring shared care plans, intelligent task management, and communication tools that function across teams and care environments. Ultimately, we are not just purchasing EHR software; we are investing in a digital foundation.
The study projects that if the funding interruption persists, Mozambique could see a 15% rise in HIV infections and a 10% increase in HIV-related deaths by the year 2030. Give your business an edge with our leading industry insights. Thank you for subscribing View all newsletters from across the GlobalData Media network.
The study authors noted that the findings suggest that long-term obesity may trigger aging-related molecular signals in young adults, which is consistent with epigenetic alterations, telomere attrition, chronic inflammation, impaired nutrient sensing, mitochondrial stress, and compromised intercellular communication. and higher.
The group had set a fundraising target of $11.9bn for its 2026-2030 budget. Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications.
As CXO, he promotes a patient-centric approach, emphasizing communication, empathy and personalized care. In her career, she has built and led integrated marketing communications programs, public relations initiatives and strategic planning for Fortune 500 companies. Caulfield came to Grady Health in 2012. Danita Cohen. Lisa Drumbore.
The report suggested health research is a key area for R&D investment to align activity with broader social goals, communicate a clear strategic direction and improve R&D funding by crowding novel investment. . percent of GDP by 2030, to level with R&D investment in Sweden, the US and Taiwan. billion over a decade.
.” “Efforts to expand access to medicines, especially insulin, are only beneficial when effective cold chain systems are in place to keep them at the right temperature on their way to patients,” commented Leigh Ann Pusey, Executive Vice President of corporate affairs and communications for Lilly.
Lilly’s 30×30 initiative aims to improve access to quality healthcare for 30 million people living in limited-resource settings, annually, by 2030. Communication with WHO encourage implementation of and accountability for the commitments and contributions toward improving access to insulin.
It is hoped this acceleration will lead to up to 10,000 patients receiving such therapies by the end of 2030. German biotech company BioNTech and the UK Government have signed a Memorandum of Understanding (MoU) which will accelerate clinical trials of personalised mRNA immunotherapies. read more.
The reusable Smart Button attaches to the top of the Tempo insulin pen, and communicates via Bluetooth with the app – a bespoke version of Welldoc’s BlueStar software – to log when shots are administered and the dose taken. billion in 2020 to more than $16 billion by 2030, according to GlobalData. The system works as follows.
2] Additionally, the number of people living with obesity in India is likely to be around 160 million by 2030. [3] In terms of diabetes alone, India houses over 100 million people living with diabetes. [1] 1] This is expected to grow to over 125 million by 2045. [2]
According to a 2018 landmark report by the Lancet Commission, the growing mental health epidemic could cost the international economy up to $16 trillion by 2030 , with a dramatic impact on productivity and quality of life. Economically speaking, Americans lose approximately $193.2
Since then, many societies have indeed made discernible progress towards digital transformation of their events and communications practices. Head of Strategic Communication, Congrex, Switzerland. Postscript. Jelmer van Ast, Founder & CEO, Conference Compass, The Hague, The Netherlands. www.conferencecompass.com.
The challenge for pharma in reducing its carbon footprint A recent study presented at COP27 , found that just 4% of biotechnology and pharmaceutical companies were currently on track to meet Paris 2030 climate goals, with the pharmaceutical industry being among the world’s largest carbon emitters.
The industry is poised for considerable growth in the near future and is expected to reach $130 billion by 2030 (currently valued at $50 billion) (1). Students here lack the basic English communication skills and require direction on career options,” highlighting the need to improve skilling in institutes at the tier-2 and tier-3 levels.
He also outlined ambitious goals for the sector, projecting “to reach $130 billion by 2030 and maybe $250 billion by 2040.” ” He also stressed that employees should be encouraged to report errors without fear, and management should support this open communication to facilitate proper corrective actions.
The alliance is another example of the shift by the pharma industry towards decentralised clinical trials (DCTs), which use technology to communicate with participants and collect data, via telemedicine and mobile/local healthcare providers, often with the help of wearable devices and sensors.
The new devices – NovoPen 6 and NovoPen Echo Plus – are insulin self-injection pens that record information such as when and how much insulin is administered, with the data uploaded to an app via near-field communication (NFC) link so it can be reviewed by the patients themselves and healthcare professionals.
Director, Patient Advocacy, Pfizer Health literacy is defined according to Healthy People 2030 as the degree to which individuals have the ability to find, understand, and use information and services to inform health-related decisions and actions for themselves and others. References: Health literacy in healthy people 2030.
It is estimated that the global people analytics market is set grow five-fold to over US$10 billion by 2030, driven by its increasing adoption, While there are several implementation success stories, many organizations still struggle to derive optimum value. As a result, HR managers also become detached when communicating with employees.
The Social Determinants of Health in the African-American community include all of the factors of the U.S. Government’s Healthy People 2030, a set of data-driven national goals for improving health for all Americans. In addition, the communication system to share analysis and the patient’s state is mediocre.
By 2030, global spending on digital health is projected to represent 8% of all healthcare expenditure, up from 3% currently 2. Funding has followed the technology, with the digital health sector seeing significant growth globally due to strong investor confidence and perceived investment opportunities.
Continued Burnout and Veterinary Staff Shortages Unemployment rates continue to affect the veterinary industry, with estimates that by 2030 there will be a shortage of 15,000 veterinarians , making the demand for more workers increasingly urgent. It often starts with communication.
According to a GlobalData epidemiology forecast, there will be nearly 190 million cases of dysphagia globally by 2030. Children are also heavily affected, with 25%-45% of paediatric patients experiencing dysphagia. China will comprise a majority at almost 120 million cases, followed by India at 35 million.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content